Biontech Se Sponsored Adr Stock News

Gainers Volt Information Sciences, Inc. (NYSE: VOLT ) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI ) shares climbed 36.5% to $4.3001. Turquoise Hill Resources Ltd. (NYSE: TRQ ) gained 32.4% to $26.68 after Rio Tinto proposed to acquire the company at C$34 per share. Mullen Automotive, Inc. (NASDAQ: MULN ) rose 27% to $1.7153 after jumping 26% on Friday. Molecular Data Inc. (NASDAQ: MKD ) rose 25.2% to $0.1930 after dropping around 12% on Friday. Alset EHome International Inc. (NASDAQ: AEI ) shares rose 20.2% to $0.5168 after jumping 24% on Friday. Moderna, Inc. (NASDAQ: MRNA ) gained 18.9% to $164.29 after the company announced the first participant has been dosed in a clinical trial of an experimental HIV trimer mRNA vaccine. BioNTech SE (NASDAQ: BNTX ) jumped 16.7% to $158.32. The Pfizer- BioNTech vaccine is only moderately effective against the omicron variant when tested in children ages 5 to 15.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

Many vaccine makers are surging in Monday trading amid concerns over a new COVID-19 variant, deltacron, and as China experiences its worst outbreak since early 2020.

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 14.8% at $155.65. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.

The Pfizer Inc (NYSE: PFE ) - BioNTech SE (NASDAQ: BNTX ) vaccine is only moderately effective against the omicron variant when tested in children ages 5 to 15. According to a study conducted by the Centers for Disease Control and Prevention (CDC) and Abt Associates, the shot showed 59% efficacy in those ages 12 to 15 and 31% in those ages 5 to 11. The study also found that vaccinated children spent less time sick in … Full story available on Benzinga.com

NEW YORK , March 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRK, LIN, BNTX, BAC, and AAPL. … Full story available on Benzinga.com

The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.

Shares of Covid-19 vaccine makers jump on news of climbing Covid-19 cases in China and growing talk of a fourth booster round in the U.S.

The market has probably priced in the impacts of its biggest source of revenue.

The market has probably priced in the impacts of its biggest source of revenue.

Even though Pfizer (PFE)/BioNTech (BNTX) COVID-19 vaccine is authorized for use in children 5-11 years old, a relatively low percentage of them have received a shot.

After months of poor performance, Moderna, BioNTech, and Novavax surged Wednesday. Bears now "are less negative" on Moderna, says one analyst.

Vaccine stocks popped Wednesday, but remain broadly under pressure. Their Covid wares are predicted to fall as the virus becomes endemic.